The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
931
September 16, 1994
View Complete Issue         Table of Contents 2019 
Oral Fluconazole for Vaginal Candidiasis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Oral Fluconazole for Vaginal Candidiasis
September 16, 1994 (Issue: 931)
Many drugs, mostly imidazole derivatives, are marketed in the USA for topical treatment of vulvovaginal candidiasis (Medical Letter, 33:81, 1991). Recently, fluconazole (Diflucan - Roerig), which is the drug of choice for treatment of ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Oral Fluconazole for Vaginal Candidiasis
Article code: 931a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.